Each year, 200,000 Americans are diagnosed with breast cancer. Six to ten percent of these diagnoses are metastatic, or stage IV, and approximately another 30% of early stage breast cancer patients go on to develop metastatic breast cancer.





METAvivor brings attention to the specific issues of stage IV metastatic breast cancer, and raise public awareness about the facts of the disease.

METAvivor awards research grants to individuals with a clinical or other doctoral degree who are actively engaged in areas of metastatic breast cancer research, and whose proposals show distinct promise in making a difference for the stage 4 breast cancer community.

A community of support is one of the most basic needs for anyone facing metastatic cancer. Although METAvivor has evolved to focus primarily on public awareness and raising funds for metastatic breast cancer research, their original support program still remains intact as its own entity.  


of donations go to metastatic breast cancer research

METAvivor is dedicated specifically to men and women with stage 4 metastatic breast cancer, and remains the sole US organization dedicated to awarding annual stage 4 breast cancer research through a scientific peer-review process. 

METAvivor Research and Support Inc. is an Annapolis-based, 501(c)(3), volunteer-led, non-profit organization founded by metastatic breast cancer (MBC) patients. EIN 37-1578088.